SenesTech, Inc. (SNES)
| Market Cap | 5.86M -76.3% |
| Revenue (ttm) | 2.37M +13.4% |
| Net Income | -7.00M |
| EPS | -1.36 |
| Shares Out | 5.42M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 37,855 |
| Open | 1.090 |
| Previous Close | 1.100 |
| Day's Range | 1.050 - 1.090 |
| 52-Week Range | 1.050 - 5.345 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About SNES
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the act... [Read more]
Financial Performance
In 2025, SenesTech's revenue was $2.22 million, an increase of 19.60% compared to the previous year's $1.86 million. Losses were -$6.38 million, 3.22% more than in 2024.
Financial StatementsNews
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Direct...
SenesTech Transcript: Lytham Partners 2026 Consumer & Technology Investor Summit
A new corporate strategy and leadership overhaul have driven record revenue, e-commerce, and subscription growth, with a focus on profitable scaling and B2B expansion. Product innovation and assessment services are enhancing customer value, while financial discipline supports a path to cashflow break-even.
SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
SURPRISE, Ariz., Aug. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast...
SenesTech Earnings Call Transcript: Q2 2026
Record Q2 revenue and gross margin were driven by e-commerce and subscription growth, with Amazon and Shopify channels setting new highs. B2B revenue showed underlying growth after adjusting for one-time items, and new assessment services and international expansion support future opportunities.
SenesTech Earnings release: Q2 2026
SenesTech released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
SenesTech Quarterly report: Q2 2026
SenesTech has published its Q2 2026 quarterly earnings report on August 5, 2026.
SenesTech reports Q2 EPS (35c) vs. (87c) last year
Reports Q2 revenue $770K vs. $625K last year. “We believe our Q2 results indicate that the strategy we put in place is working,” said CEO Michael Edell. “We achieved record…
SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates
Revenue rose 56% sequentially and gross margin reached a company-record 73.6% in the first full quarter of in-house Amazon management, advancing the Company's intended shift to a scalable, recurring-r...
SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations
New assessment services complement existing implementation and deployment services to develop the most effective solution for each customer's rodent problem. SURPRISE, Ariz.
SenesTech reports subscriber base more than doubled in Q2
SenesTech (SNES) announced that its active online subscription customer base, comprising both direct-to-consumer, or DTC, and business-to-business, or B2B, customers, more than doubled during the Q2 c...
SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum
Integrated e-commerce strategy drives recurring revenue while supporting long-term growth across consumer and business-to-business markets. SURPRISE, Ariz.
SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, July 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertil...
SenesTech announces results from use of Evolve Rat Birth Control
SenesTech (SNES) announced successful results from the use of Evolve Rat Birth Control at a 400-acre farming operation in Dalhart, Texas, where rodents had been causing persistent damage to undergroun...
SenesTech's Evolve® Delivers Significant Reduction in Rodent Damage at Texas Agricultural Operation
SURPRISE, Ariz., July 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, today announced successful results from the use o...
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizations SURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ...
SenesTech expands distribution of Evolve Rodent Birth Control into Bermuda
SenesTech (SNES) announced the expansion of its Evolve Rodent Birth Control products into Bermuda through a distribution agreement with Animal and Garden House. Other existing and expanding deployment...
SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda
SURPRISE, Ariz., June 4, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced the expansion of its Evolve® Rodent B...
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on June 4, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Announces Amendment to Equity Incentive Plan Proposal
PHOENIX, June 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), today announced that its Board of Directors has approved an amendment to the proposed changes to th...
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on June 3, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Transcript: Lytham Partners Spring 2026 Investor Conference
A new CEO with deep consumer products experience is leading a strategic shift to prioritize direct-to-consumer growth, recurring revenue, and brand awareness, while revamping B2B approaches for targeted verticals. Operational improvements and a focus on profitability and accountability are expected to drive measurable progress.
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on May 27, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
SURPRISE, Ariz., May 19, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Bir...
SenesTech reports Q1 EPS (39c) vs. ($1.28) last year
Reports Q1 revenue $493,000 vs. $485,000 last year. “SenesTech (SNES) is entering a new phase where we are building a more scalable, data-driven and recurring revenue business model around the…
SenesTech Earnings Call Transcript: Q1 2026
Q1 2026 saw record growth in direct-to-consumer, subscription, and B2B revenues, with gross margin reaching 68.6%. Strategic shifts to in-house Amazon management and a focus on recurring revenue are driving momentum, and management expects continued quarter-over-quarter growth.